Skip Navigation


PROTAC® Protein Degrader Technology: Leading the Way in Targeted Protein Degradation Therapeutics
Learn More

Our Therapeutic Programs

We are rapidly advancing our wholly owned pipeline of targets in oncology and neurodegeneration, including next generation targets that have traditionally been “undruggable.”

What’s New

What drives us

Every day at Arvinas, we advance pioneering science to develop new, transformative treatments for patients with limited treatment options, or for whom existing treatments have not been effective.

Our Values

Our values drive the work we do and the way we collaborate.



Unfortunately, it is hard to find anyone whose life is not touched by cancer or neurodegenerative disease. Our engagement with the patient community keeps us focused on our mission.


Join the Conversation

We’re very social. Chat with us on Twitter or LinkedIn!

We're Hiring

We’re really excited about the work we’re doing inside and outside of Arvinas, and think you will be, too. Check out our open positions, we’d love to hear from you.

Open Positions
What new hiring


PROTAC technology was invented at Yale University in New Haven, CT by the leading pioneer in the field, and we've been here ever since. We are proud of our New Haven roots and are committed to its emerging biotech community.

What new community


We see expansive potential for our PROTAC platform and we work with partners to extend its utility and reach, both in human therapeutics and crop protection.

Genentech logo
Pfizer logo
Bayer logo
OerthBio logo
View Partnerships